Fig. 3From: Integrative multi-omics analysis depicts the methylome and hydroxymethylome in recurrent bladder cancers and identifies biomarkers for predicting PD-L1 expressionMethylation alternations in PD-L1 highly expressed bladder cancer. A The number of 5mC and 5hmC differentially methylated regions (DMRs) identified in PD-L1 highly expressed bladder cancer samples (left). The genomic annotations of 5mC and 5hmC DMRs (right). B Heatmap showing the methylation alternations in 5mC DMR biomarkers in PD-L1 highly expressed bladder cancer samples. C Scatter plot showing the correlation between differential 5hmC levels and differential 5mC levels in PD-L1 highly expressed bladder cancerBack to article page